Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
39.63
-0.34 (-0.85%)
At close: Feb 17, 2026, 4:00 PM EST
39.00
-0.63 (-1.59%)
After-hours: Feb 17, 2026, 6:45 PM EST
Corcept Therapeutics Employees
Corcept Therapeutics had 500 employees as of December 31, 2024. The number of employees increased by 148 or 42.05% compared to the previous year.
Employees
500
Change (1Y)
148
Growth (1Y)
42.05%
Revenue / Employee
$1,482,344
Profits / Employee
$209,312
Market Cap
4.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 500 | 148 | 42.05% | 500 | 0 |
| Dec 31, 2023 | 352 | 53 | 17.73% | 352 | 0 |
| Dec 31, 2022 | 299 | 61 | 25.63% | 299 | 0 |
| Dec 31, 2021 | 238 | 2 | 0.85% | 238 | 0 |
| Dec 31, 2020 | 236 | 30 | 14.56% | 236 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 685 |
| ACADIA Pharmaceuticals | 654 |
| Amicus Therapeutics | 499 |
| Crinetics Pharmaceuticals | 437 |
| TG Therapeutics | 374 |
| Apogee Therapeutics | 196 |
| Arcellx | 163 |
| CG Oncology | 113 |
CORT News
- 5 hours ago - Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call - Business Wire
- 8 days ago - CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 8 days ago - Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT - PRNewsWire
- 13 days ago - Allspring Emerging Growth Fund Q4 2025 Performance Review - Seeking Alpha
- 13 days ago - Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman - GlobeNewsWire
- 18 days ago - Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing - Business Wire
- 18 days ago - Berman Tabacco Announces Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT) Concerning FDA New Drug Application - GlobeNewsWire
- 18 days ago - Corcept shares tumble after FDA letter reveals warnings before drug rejection - Reuters